Establishment of a Method for Mapping of N-Linked Oligosaccharides and Its Use to Analyze Industrially Produced Recombinant Erythropoietin
スポンサーリンク
概要
- 論文の詳細を見る
A rapid and convenient method for N-linked oligosaccharide structure analysis was developed and applied to the quality examination of commercially manufactured recombinant human erythropoietin (rEPO). Oligosaccharides released from rEPO expressed in Chinese hamster ovary cells were labeled with 2-aminobenzamide, and analyzed by a combination of diethylaminoethyl (DEAE) column HPLC and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). This newly developed method allowed us to analyze sialylated oligosaccharides directly. The results showed that these oligosaccharides are composed of neutral-mono-di-tri-tetrasialyl oligosaccharides in a ratio of<1 : 2 : 13 : 34 : 51%, and that the core structure was a mixture of complex type bi-, tri- and tetra-antennary forms with one to three polylactosaminyl chains. Further analysis showed clearly that the N-linked oligosaccharide structure of rEPO has not changed throughout the past ten years of manufacturing by our company. The analysis was carried out using a small quantity (1 nmol) of rEPO, demonstrating the efficacy of the newly developed method. Further, the N-linked oligosaccharides of rEPO manufactured by our company almost coincided with those of the erythropoietin European Pharmacopoeia Biological Reference Preparation (Eur.Ph.BRP), a standard product.
- 公益社団法人日本薬学会の論文
- 1999-04-15
著者
-
SASAKI Hiroshi
Pharmacognosy and Medicinal Resources Research Department, Central Research Laboratories, Tsumura &
-
Fukuda M
The Burnham Institute La Jolla Cancer Research Center
-
Itoh M
Pharmaceutical Production Division Chugai Pharmaceutical Co. Ltd.
-
KANAZAWA Koki
Pharmaceutical Production Division, Chugai Pharmaceutical Co., Ltd.
-
ASHIDA Kyoko
Pharmaceutical Production Division, Chugai Pharmaceutical Co., Ltd.
-
ITOH Masao
Pharmaceutical Production Division, Chugai Pharmaceutical Co., Ltd.
-
NAGAI Hiroshi
Pharmaceutical Production Division, Chugai Pharmaceutical Co., Ltd.
-
FUKUDA Minoru
The Burnham Institute, La Jolla Cancer Research Center
-
Kanazawa Koki
Pharmaceutical Production Division Chugai Pharmaceutical Co. Ltd.
-
Ashida Kyoko
Pharmaceutical Production Division Chugai Pharmaceutical Co. Ltd.
-
Fukuda Minoru
The Burnham Institute La Jolla Cancer Research Center
-
Sasaki Hiroshi
Pharmaceutical Production Division Chugai Pharmaceutical Co. Ltd.
-
Nagai Hiroshi
Pharmaceutical Production Division Chugai Pharmaceutical Co. Ltd.
-
Sasaki Hiroshi
Pharmaceutical Institute, Tohoku University
関連論文
- Identification of Medicinal Atractylodes Based on ITS Sequences of nrDNA(Pharmacognosy)
- Inhibitory effects of compounds from Anemarrhenae Rhizoma on α-glucosidase and aldose reductase and its contents by drying conditions
- Establishment of a Method for Mapping of N-Linked Oligosaccharides and Its Use to Analyze Industrially Produced Recombinant Erythropoietin
- Photoinduced potential changes across poly(vinyl chloride)/crown ether membranes. Membrane potential in the presence of alkaline earth metal cations.
- Photoinduced extraction and active transport of anions by a triphenyl methane derivative.